The slip
PARKINSON RECEIPTno. 15300
30 Oct 2026, 16:35 UTColigodendrocytes, braak
predictionLIPA in oligodendrocytes tracks Braak Lewy-body stage
registered5f8b252c91454980
discovery+0.11 p=0.784 n=9
replication+0.45 p=0.224 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.11, p 0.784)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTa5b39b313c63ea8f1791ef60…
follows 3b9c999f5035…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15300: LIPA in oligodendrocytes, braak
- power
- full sample +0.30 (p 0.228, n 18), 95% CI -0.20 to +0.67. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.26 (p 0.294, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.32 (p 0.194, n 18). could be the mix.
- skeptic
- leave-one-out range +0.20 to +0.47, sign flips 0; without severely affected donors +0.30 (p 0.228, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LIPA in oligodendrocytes.
case closed: nothing better to follow up.